AZN Q1 2026 Earnings EPS Falls Slightly Short of Consensus Stock Edges Lower CDP Q1 2026 Earnings Modest EPS Beat Amidst Steady DefenseOriented Portfolio Turn Therapeutics Inc TTRX Q1 2026 Earnings Narrow EPS Miss Overshadowed by Operational Progress HBAN Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher CrossAmerica Partners LP CAPL Q1 2026 Earnings Strong Earnings Surprise Despite Challenging Fuel Market Grace Therapeutics Q1 2026 Earnings EPS Surprise of 5098 Despite No Revenue as Stock Declines